These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 9261249

  • 21. [Metabolic impact of current estrogen-progestins and cardiovascular consequences].
    Gaspard U, Lambotte R.
    Bull Mem Acad R Med Belg; 1991; 146(8-10):334-42; discussion 342-5. PubMed ID: 1815814
    [Abstract] [Full Text] [Related]

  • 22. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone.
    Akerlund M, Almström E, Högstedt S, Nabrink M.
    Acta Obstet Gynecol Scand; 1994 Feb; 73(2):136-43. PubMed ID: 8116352
    [Abstract] [Full Text] [Related]

  • 23. Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.
    Lepot MR, Gaspard UJ.
    Int J Fertil; 1987 Feb; 32 Suppl():15-20. PubMed ID: 2906343
    [Abstract] [Full Text] [Related]

  • 24. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P, Walden C, Knopp R, Hoover J, Wallace R, Heiss G, Rifkind B.
    N Engl J Med; 1983 Apr 14; 308(15):862-7. PubMed ID: 6572785
    [Abstract] [Full Text] [Related]

  • 25. A randomized comparative open study of the effects of two oral contraceptives, Triphasil and Ortho 7/7/7, on lipid metabolism.
    Kakis G, Powell M, Marshall A, Steiner G.
    Contraception; 1993 Feb 14; 47(2):131-48. PubMed ID: 8449014
    [Abstract] [Full Text] [Related]

  • 26. Comparison of the lipoprotein, carbohydrate, and hemostatic effects of phasic oral contraceptives containing desogestrel or levonorgestrel.
    Knopp RH, Broyles FE, Cheung M, Moore K, Marcovina S, Chandler WL.
    Contraception; 2001 Jan 14; 63(1):1-11. PubMed ID: 11257242
    [Abstract] [Full Text] [Related]

  • 27. Comparison of the effects of triphasic oral contraceptives with desogestrel or levonorgestrel on apolipoprotein A-I-containing high-density lipoprotein particles.
    Cheung MC, Walden CE, Knopp RH.
    Metabolism; 1999 May 14; 48(5):658-64. PubMed ID: 10337871
    [Abstract] [Full Text] [Related]

  • 28. Comparative effects of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic) on lipid profiles. Investigators from the Lunelle Study Group.
    Cromie MA, Maile MH, Wajszczuk CP.
    Contraception; 2000 Jan 14; 61(1):51-9. PubMed ID: 10745070
    [Abstract] [Full Text] [Related]

  • 29. A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
    Skouby SO, Endrikat J, Düsterberg B, Schmidt W, Gerlinger C, Wessel J, Goldstein H, Jespersen J.
    Contraception; 2005 Feb 14; 71(2):111-7. PubMed ID: 15707560
    [Abstract] [Full Text] [Related]

  • 30. Comparison of the metabolic effects of two hormonal contraceptive methods: an oral formulation and a vaginal ring. II. Serum lipoproteins and apolipoproteins.
    Ahrén T, Lithell H, Victor A, Vessby B, Johansson ED.
    Contraception; 1981 Oct 14; 24(4):451-68. PubMed ID: 6797786
    [Abstract] [Full Text] [Related]

  • 31. Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: comparison with changes occurring during oral contraceptive therapy.
    Lussier-Cacan S, Xhignesse M, Desmarais JL, Davignon J, Kafrissen ME, Chapdelaine A.
    Metabolism; 1991 Aug 14; 40(8):849-54. PubMed ID: 1907348
    [Abstract] [Full Text] [Related]

  • 32. Dietary polyunsaturated fat decreases interaction between low density lipoproteins and arterial proteoglycans.
    Manning JM, Gebre AK, Edwards IJ, Wagner WD, Rudel LL, Parks JS.
    Lipids; 1994 Sep 14; 29(9):635-41. PubMed ID: 7815898
    [Abstract] [Full Text] [Related]

  • 33. A norgestimate-containing oral contraceptive: review of clinical studies.
    Kafrissen ME.
    Am J Obstet Gynecol; 1992 Oct 14; 167(4 Pt 2):1196-202. PubMed ID: 1415446
    [Abstract] [Full Text] [Related]

  • 34. Comparative effects of monophasic desogestrel plus ethinyloestradiol and triphasic levonorgestrel plus ethinyloestradiol on lipid metabolism.
    Kloosterboer HJ, van Wayjen RG, van den Ende A.
    Contraception; 1986 Aug 14; 34(2):135-44. PubMed ID: 2946552
    [Abstract] [Full Text] [Related]

  • 35. Effects of oral contraceptives on lipoprotein triglyceride and cholesterol: relationships to estrogen and progestin potency.
    Knopp RH, Walden CE, Wahl PW, Hoover JJ.
    Am J Obstet Gynecol; 1982 Mar 15; 142(6 Pt 2):725-31. PubMed ID: 7065054
    [Abstract] [Full Text] [Related]

  • 36. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW, Chenault CB, de la Peña A, Dozier TS, Kraemer DC.
    Fertil Steril; 1978 Nov 15; 30(5):522-33. PubMed ID: 214353
    [Abstract] [Full Text] [Related]

  • 37. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins.
    Crook D, Godsland IF, Wynn V.
    Am J Obstet Gynecol; 1988 Jun 15; 158(6 Pt 2):1612-20. PubMed ID: 3287933
    [Abstract] [Full Text] [Related]

  • 38. Role of apolipoprotein E on cholesteryl ester-enriched low density lipoprotein particles in coronary artery atherosclerosis of hypercholesterolemic nonhuman primates.
    Stevenson SC, Sawyer JK, Rudel LL.
    Arterioscler Thromb; 1992 Jan 15; 12(1):28-40. PubMed ID: 1731856
    [Abstract] [Full Text] [Related]

  • 39. Changes in lipoprotein composition in women receiving two low-dose oral contraceptives containing ethinylestradiol and gonane progestins.
    Harvengt C, Desager JP, Gaspard U, Lepot M.
    Contraception; 1988 Jun 15; 37(6):565-75. PubMed ID: 2969320
    [Abstract] [Full Text] [Related]

  • 40. Changes in serum apo-lipoprotein AI and sex-hormone-binding globulin levels after treatment with two different progestins administered alone and in combination with ethinyl estradiol.
    Crona N, Silfverstolpe G, Samsioe G.
    Contraception; 1984 Mar 15; 29(3):261-70. PubMed ID: 6234148
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.